Bristol-Myers Squibb (NY:BMY)

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

December 10, 2025

Bristol Myers Squibb Announces Dividend Increase

December 10, 2025

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

2 Pharmaceutical Stocks to Buy at a Discount ↗

December 10, 2025

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for...

Topics Intellectual Property

1 Large-Cap Stock on Our Buy List and 2 We Turn Down

December 08, 2025

Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025

December 08, 2025

These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?

Do These 3 Healthcare Stocks Need a Checkup? ↗

December 05, 2025

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

Topics Intellectual Property

December 04, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

3 Stocks Under $50 We’re Skeptical Of

December 03, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Which S&P500 stocks are moving on Wednesday? ↗

December 03, 2025

Via Chartmill

What's going on in today's session: S&P500 movers ↗

December 03, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

Bristol Myers Stock Jumps As Wall Street Backs Added Enrollment In Alzheimer’s Trial — Retail Calls It ‘Worth A Play’ ↗

December 03, 2025

Bristol Myers’ ADEPT-2 update drew support from JPMorgan and William Blair following the decision to continue the study with added enrollment.

Via Stocktwits

These S&P500 stocks are moving in today's pre-market session ↗

December 03, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease

December 03, 2025

Amazon (NASDAQ: AMZN) has unveiled a groundbreaking class of AI agents, dubbed "frontier agents," capable of operating autonomously for extended periods—even days—without constant human intervention....

Amazon Unleashes AI Frontier Agents: A New Era of Autonomous Digital Workers

December 02, 2025

Via TokenRing AI

Topics Artificial Intelligence Economy

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

Via Investor Brand Network

Topics Government

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

Bristol-Myers Squibb Co (NYSE:BMY) Presents a Compelling Value Investment Case ↗

December 02, 2025

Bristol-Myers Squibb (BMY) presents a value investment case, trading at a deep discount with strong earnings power and a high dividend amid near-term challenges.

Via Chartmill

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

December 01, 2025

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever ↗

November 30, 2025

Patience will be rewarded for those who stick with these two healthcare stocks.

Topics Intellectual Property

2 Top Dividend Stocks to Buy and Hold ↗

November 30, 2025

The pharma stock yields more than 4x the S&P 500 average.

Topics Artificial Intelligence Intellectual Property

Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend? ↗

November 29, 2025

Bristol-Myers (BMY) Earnings Call Transcript

Topics Intellectual Property Stocks

Bristol-Myers (BMY) Earnings Call Transcript ↗

November 27, 2025

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a Compelling Mix of High Yield and Financial Strength for Dividend Investors ↗

Topics Earnings

November 27, 2025

Bristol-Myers Squibb (BMY) offers a strong 5.4% dividend yield, backed by a history of reliable payments, robust profitability, and a sound financial position for income investors.

Via Chartmill

Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference

November 26, 2025

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma

November 24, 2025

PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies...

Curious about the S&P500 stocks that are gapping on Monday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Topics Economy

Monday's session: gap up and gap down stock in the S&P500 index ↗

November 24, 2025

Via Chartmill

Which S&P500 stocks are moving before the opening bell on Monday? ↗

November 24, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

Bristol Myers Squibb to Host Hematology-Focused Investor Event

November 24, 2025